Hydrogel nasal spray could cut insulin injections; Soligenix has fast track designation for pediatric Crohn's;

> Many researchers are tackling the puzzle of insulin delivery and how to take the burden of daily injections away from insulin-dependent diabetics. A hydrogel in development could make insulin delivery as simple as a once-a-day nasal spray. Abstract | Article

> CRO Particle Sciences has developed an ocular formulation for its client, Eyeon Therapeutics, to deliver a treatment for dry eye. Press release

> Insmed has completed target enrollment of the Phase III clinical trial of ARIKACE (inhaled liposomal amikacin) in cystic fibrosis patients with pseudomonas lung infections. Press release

> An antibody-drug conjugate targeting prostate cancer cells was well-tolerated in Phase I trials with early signs of activity, and a Phase II trial is under way. Press release

> The FDA has granted Soligenix fast track designation for SGX203 (immediate and delayed-release tablet) for mild-to-moderate pediatric Crohn's disease. Press release

> CellAct Pharma's etoposide prodrug shows signs of activity in advanced cancer Phase I study. Press release

> Colby Pharmaceutical has licensed rights to intra-lymph node delivery technologies from MannKind. Article

And Finally… In an almost Halloween story, a protein-based gel that moves on its own could deliver drugs. Article

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.